The next generation of Precision Medicine.
Persona Biomed is building a next-generation precision diagnostics and clinical-intelligence platform designed to move medicine from static, organ-centric testing toward system-level molecular insight. The company’s core thesis is that disease begins and evolves at the molecular-systems level long before abnormalities appear on routine laboratory tests or imaging, and that clinicians today need tools that translate those early molecular disturbances into actionable clinical intelligence. Persona Biomed aims to fill this gap by combining blood-based laboratory-developed tests, multi-analyte biomarker panels, composite biomarker indices, and AI-assisted clinical interpretation into an integrated diagnostic and decision-support platform.
Advanced biomarker analysis and AI interpretation.
Rather than functioning as a conventional specialty laboratory that reports isolated biomarkers, Persona Biomed positions itself as a complementary diagnostics platform that bridges laboratory data, imaging, and clinical decision-making. Its PMCI technology interprets inter-organ molecular communication networks across major biological axes, including the blood–brain barrier neurovascular axis, the immunometabolic axis, the angiofibrogenic cardioremodeling axis, the brain-bone axis and the gut–to–brain hepatopulmonary axis (PBM-Dx).
The company’s service portfolio spans both non-oncology and oncology applications, including tests for blood–brain barrier neurovulnerability, cardioremodeling risk, obese immunometabolic subtypes, multisystem foundational health, osteoporosis subtypes, and transcriptional immunocarcinogenic profiling across major malignancies that identify cancer regulation phenotype and metastasis risk.
Concierge-level clinical insight you need to act.
Persona Biomed is not selling raw laboratory outputs; it is selling interpretation and clinical intelligence layered on top of molecular profiling and phenotyping, which transform complex molecular data into clinically actionable intelligence, and enable more personalized prevention, earlier disease detection, and more confident management of chronic disease. Altogether, it empowers concierge physicians to deliver a deeper level of precision medicine that combines advanced diagnostics, thoughtful AI interpretation, and high-touch medical care to strengthen the distinctive value proposition of concierge medicine.
Comprehensive
- 200+ molecular biomarkers for blood testing of acute and chronic diseases (go to PBM-Dx™ Blood Tests)
- 150+ immuno-carcinogenic and prometastatic genes for the transcriptional profiling of most aggressive malignancies (go to PBM-Dx™ Cancer Tests)
Concierge.
- Our AI-assisted clinical interpretation reports for 25+ clinical applications of 5 blood tests (go to PBM-Dx™ Blood Tests)
Trusted and Secure Digital Ecosystem (go to PBM-Dx™)
- Every patient gains access to a personalized digital portal that stores results, reports, and historical trends.
- Reports are available for download, with the option to share securely with providers and care teams.
- Built-in eCommerce functionality supports test ordering, subscription management, and integrated care solutions.
Data Security & Clinical Privacy Standards
- Patient data is processed in secure environments with encrypted transmission.
- AI agents operate within strict boundaries, without training on user data.
- Personally identifiable data is handled under HIPAA/GDPR-compliant protocols.
- Reports are generated autonomously with structured, rule-based medical logic.
- Full traceability and audit logs ensure transparency in clinical interpretation.
- Privacy-by-design and minimal-data-principle guide all system components.